Generics versus brand-named drugs for glaucoma: the debate continues.
Rom J Ophthalmol
; 64(3): 239-244, 2020.
Article
en En
| MEDLINE
| ID: mdl-33367157
There are three options for a given class of drugs, including brand name drugs, generic and branded generic drugs. Brand name drugs are costlier as compared to generic and branded generic drugs because they are innovator molecules developed by a company after many years of research and come into the market with a patent, whereas branded generic drugs are produced by a different company once the patent of innovator company expires. Given that glaucoma is a chronic, largely asymptomatic disease, the choice of drugs is extremely important: the duration of medication is often lifelong, and the cost of drugs, side effects and efficacy affect compliance and adherence to therapy. This review is a brief overview of the available brand name and branded generic drugs for the management of glaucoma, in terms of efficacy and side effect profiles. It also aimed to guide rational and pragmatic drug choices in different clinical scenarios.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Glaucoma
/
Medicamentos Genéricos
/
Antihipertensivos
Límite:
Humans
Idioma:
En
Revista:
Rom J Ophthalmol
Año:
2020
Tipo del documento:
Article
País de afiliación:
India
Pais de publicación:
Rumanía